Table 1.
Characteristics of LUSC patients in the training set and validation set.
| TCGA-LUSC cohort (n = 394) | GSE4573 cohort (n = 130) | Statistical value | p value | |
|---|---|---|---|---|
| Age (median [IQR]) | 68 ([62, 73]) | 68 ([60, 75]) | -0.35a | 0.726 |
| Gender (%) | 6.426 | 0.011∗ | ||
| Female | 100 (25.4) | 48 (36.9) | ||
| Male | 294 (74.6) | 82 (63.1) | ||
| pT stage (%) | 0.301 | 0.583 | ||
| 1-2 | 322 (81.7) | 109 (83.8) | ||
| 3-4 | 72 (18.3) | 21 (16.2) | ||
| pN stage (%) | 0.007 | 0.935 | ||
| N0 | 250 (63.5) | 83 (63.8) | ||
| N1-N3 | 144 (36.5) | 191 (36.2) | ||
| pTNM stage (%) | 0.163 | 0.687 | ||
| I-II | 318 (80.7) | 107 (82.3) | ||
| III-IV | 76 (19.3) | 23 (17.7) |
aMann–Whitney U test. ∗p < 0.05.